BRENDA LAWRIE: Open Payments
NPI 1114481603 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 22 payments from 6 companies in 2025. Trend: 2023 $228 · 2024 $343 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $148 |
| Novo Nordisk Inc | 4 | $93 |
| Esperion Therapeutics, Inc. | 4 | $71 |
| Medtronic, Inc. | 1 | $46 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: Wegovy, NEXLETOL, WINREVAIR, VERQUVO, PULSESELECT, SHINGRIX, JARDIANCE, CAPVAXIVE.
Industry payments across OK — which companies pay providers there.
